Ward, Carl C.
Innovative Genomics Institute · University of California, Berkeley
7 papers on CoChatORCID 0000-0002-1188-4839
Most cited papers
- Verified
Harnessing the anti-cancer natural product nimbolide for targeted protein degradation
Spradlin, J. N., Hu, X., Ward, C. C., Brittain, S. M., Jones, M. D., Ou, L., To, M., Proudfoot, A., Ornelas, E., Woldegiorgis, M., et al. (2019) · Nature Chemical Biology
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 432
- Verified
Deubiquitinase-targeting chimeras for targeted protein stabilization
Henning, N. J., Boike, L., Spradlin, J. N., Ward, C. C., Liu, G., Zhang, E., Belcher, B. P., Brittain, S. M., Hesse, M. J., Dovala, D., et al. (2022) · Nature Chemical Biology
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 344
- Verified
Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
Ward, C. C., Kleinman, J. I., Brittain, S. M., Lee, P. S., Chung, C. Y. S., Kim, K., Petri, Y., Thomas, J. R., Tallarico, J. A., McKenna, J. M., et al. (2019) · ACS Chemical Biology
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 336
- Verified
NHS-Esters As Versatile Reactivity-Based Probes for Mapping Proteome-Wide Ligandable Hotspots
Ward, C. C., Kleinman, J. I., & Nomura, D. K. (2017) · ACS Chemical Biology
Click Chemistry and ApplicationsChemical Synthesis and Analysis
Cited by 158
- Verified
Ligandability of E3 Ligases for Targeted Protein Degradation Applications
Belcher, B. P., Ward, C. C., & Nomura, D. K. (2023) · Biochemistry
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 132
- Verified
Activity-based protein profiling for mapping and pharmacologically interrogating proteome-wide ligandable hotspots
Roberts, A. M., Ward, C. C., & Nomura, D. K. (2017) · Current Opinion in Biotechnology
Click Chemistry and ApplicationsAdvanced Proteomics Techniques and Applications
Cited by 108
- Verified
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2
Biering, S. B., Van Dis, E., Wehri, E., Yamashiro, L. H., Wrynla, X. H., Dugast-Darzacq, C., Graham, T. G. W., Stroumza, J. R., Golovkine, G. R., Roberts, A. W., et al. (2021) · ACS Infectious Diseases
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free